Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from melanoma

Drugs for common eye condition could be used to treat cancer, experts say

Scientists at The Institute for Cancer Research say repurposing drugs could mean they reach patients faster

The Independent UK

UCLA Wins $3.9 Million to Test Drugs That Might Make Melanoma Immunotherapy Work for More Patients

UCLA received a $3.9M NCI grant to test two compounds aimed at making melanoma immunotherapy work in more patients. What the funding does and does not cover.

Medical Daily

FDA advisers backed Replimune's RP1 melanoma therapy, bringing the investigational skin cancer drug closer to approval for advanced melanoma.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Aust cancer researcher nears personalised immunotherapy

Ines Pires da Silva didn't sit on her laurels after winning a major science prize - she is ever closer to personalising immunotherapy for cancer patients.

AAP

FDA Advisers Back a Melanoma Treatment for Patients Who Ran Out of Options, and a Decision Is Due Monday

FDA advisers voted 10-3 to back Replimune's RP1 for advanced melanoma after two rejections. The agency's decision is due August 2.

Medical Daily

Dermatologists sound the alarm as tanning becomes trendy again

This concerning trend comes as the American Cancer Society projects over 100,000 new melanoma diagnoses in the U.S. by 2026

The Independent UK

FDA Reviewers Say Melanoma Trial Data Cannot Be Verified as Advisers Weigh a Third Review

FDA reviewers say Replimune's RP1 melanoma data confound interpretation. Advisers meet July 30 ahead of an August 2 decision on a third review.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

FDA Advisers Meet Thursday on a Melanoma Therapy the Agency Says It Cannot Interpret

FDA advisers review Replimune's melanoma therapy Thursday. The agency's own briefing documents question the interpretability of the trial data.

Medical Daily

Gray Hair Reason Found: A Japanese study explains why people get grey hair and it may be linked to cancer

Why Do People Get Grey Hair: New research in Japan suggests grey hair may signal a body's protective response against Cancer. Stem cells shut down after severe DNA damage, preventing harm, however, certain carcinogens can cause these cells to multiply unchecked. This process can lead to melanoma, the most dangerous…

The Economic Times

Man who went to opticians for reading glasses diagnosed with melanoma

Ocular melanoma affects about 750 people a year in the UK but doesn’t always cause symptoms - making eye tests vital for spotting it

The Independent UK

Shatner's Final Frontier? 'Star Trek' Icon and Daughter Confront Stage 4 Cancer at the Same Time

William Shatner and his daughter Melanie reveal how they battled stage 4 cancers at the same time, with immunotherapy and targeted treatments helping both become cancer-free.

Medical Daily

'Star Trek' star William Shatner, 95, reveals he & his daughter fought separate stage 4 cancers together: 'It changed my life'

William Shatner and his daughter Melanie Shatner shared their Stage 4 cancer diagnoses. Melanie battled breast cancer while William faced malignant melanoma. Both are now cancer-free after undergoing treatment and recovery. Their shared health challenges strengthened their family bond significantly. They are launching a podcast to discuss resilience and life…

The Economic Times

William Shatner and daughter reveal they faced stage four cancer at same time

The Star Trek actor was diagnosed with stage four malignant melanoma that spread to his lungs and brain.

Evening Standard

Star Trek Legend, William Shatner, Opens Up About Experience After Becoming Cancer-Free

William Shatner says a stage 4 melanoma diagnosis three years ago changed his perspective on life and family. The Star Trek icon shared that both he and his daughter are now cancer-free thanks to treatment.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Times Life

Why Your Nails Are a Serious Health and Wellness Indicator That Most Indians Ignore

The Nail as a Diagnostic SurfaceYour nails grow approximately 3.5 millimetres per month, and every millimetre is a record of what was happening inside your body at the time it formed. A dermatologist reading a nail plate is doing something close to what a geologist does with rock strata, each…

Medical Daily

A UCLA study in iScience found creatine may fuel dendritic immune cells that activate cancer-fighting T cells, slowing tumor growth in mice and boosting human immune cells in lab tests.

Medical Daily

Scientists Discovered a Hidden Immune Backup System That Could Make mRNA Cancer Vaccines Far More Powerful

Washington University researchers found mRNA cancer vaccines activate an unexpected backup immune pathway. The Nature study could help improve vaccines for melanoma, lung cancer, and more.

Marie Claire

The Healthy Sun Exposure Debate Is Here—What's Hype, What's Dangerous, and What's Actually True

My take as a longtime beauty editor.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

The sunburns that can change your life: Experts say just 5 can double cancer risk

Getting five or more blistering burns between the ages of 15-20 increases melanoma risk by 80 percent

The Guardian - US

Tiny Antarctic sea creature could be key to treating melanoma, researchers say

Underwater expedition by Florida-based team supports possible therapeutic use of bacterial toxins from sea squirts

The Economic Times

Alembic Pharma gets tentative nod from USFDA for generic cancer drug

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step for the company in the cancer treatment drug market. The approval is for the 45mg strength, with potential for marketing exclusivity. Alembic previously received tentative approval for the 15mg strength. Binimetinib…

Medical Daily

Personalized mRNA Cancer Vaccine Shows Five-Year Data Stunning Oncologists with 69 Percent of Stage III IV Melanoma Patients Cancer-Free

ASCO 2026 (June 3, 2026) and Journal of Clinical Oncology: Intismeran autogene + Keytruda shows 49% sustained recurrence reduction at 5 years, 59% distant metastasis reduction, and 53% overall survival benefit in high-risk Stage III/IV melanoma. 69% of combination patients are cancer-free at 5 years.

The Independent UK

How toxic masculinity and TikTok could be giving you skin cancer

LET’S UNPACK THAT: As cases of melanoma reach record highs in the UK, influencers are railing against sun cream and men are avoiding it to seem tough. Helen Coffey looks at the real dangers of not lathering up and how proper messaging can save lives

AAP

FED:State funeral for research pioneer as cancer fight ends

"Remarkable" melanoma pathologist and former Australian of the Year Richard Scolyer, who died from brain cancer aged 59, will have a state funeral.

AAP

FED:Scientist Richard Scolyer dies after cancer battle

World-renowned melanoma pathologist and former Australian of the Year Richard Scolyer has died from brain cancer aged 59.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Washington University

Washington University School of Medicine

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.